Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43116 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43132 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2018-06-22 | 2018-10-11 | 52823 |
| CARBOPLATIN INJECTION | 10MG | LIQUID | Resolved | 2018-09-12 | 2018-10-11 | 61362 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2018-09-12 | 2018-10-11 | 61365 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-03-17 | 2018-10-11 | 3362 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9939 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9922 |
| ACT OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-24 | 2018-10-11 | 10975 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Actual shortage | 2017-11-16 | 2018-10-11 | 29438 |
| TEVA-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-09-27 | 2018-10-12 | 62458 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2018-08-31 | 2018-10-20 | 59704 |
| ACT FAMCICLOVIR | 125MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65497 |
| ACT FAMCICLOVIR | 250MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65502 |
| ACT FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65500 |
| ACT FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65507 |
| ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
| ACT OLOPATADINE 0.1% | 0.1% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65519 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-06-15 | 2018-11-08 | 52488 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |